Bindinglaw

US · guidance

CMS Pub. 100-02, ch. 15, § 320.6.2

Remote Monitoring and Monitoring Services

activein force · 2026-08-25 – presentas-observed

Qualified home infusion therapy suppliers are required to ensure the safe and effective

provision and administration of home infusion therapy on a 7-day-a-week, 24-hour-a-day

basis. Monitoring the patient receiving infusion therapy in their home is an important

standard of practice that is an integral part of providing medical care to patients in their

home. The expectation is that home infusion therapy suppliers would provide ongoing

patient monitoring and continual reassessment of the patient to evaluate response to

treatment, drug complications, adverse reactions, and patient compliance.

The plan of care would indicate the need for routine monitoring and specify the interval

for evaluation and documentation of patient-reported response to therapy, any adverse

effects or infusion complications, verify pump rate, obtain blood work, and obtain any

necessary vital signs. Direct communication and coordination with the patient,

caregivers, and clinicians regarding any change in the patient’s condition is on-going so

that any adjustment to treatment is made as needed and in a timely fashion. This can be

done remotely or directly during in-home patient visits at specified intervals.

Remote monitoring may be performed through telephone or other electronic

communication, based on the plan of care and the patient’s preference of communication.

Remote monitoring may include the use of a telecommunications system through which

patients are monitored by electronic submission of self-obtained vital signs, such as

weight, blood pressure, and heart rate. The patient must be instructed on obtaining vital

signs and on self-monitoring equipment use. An off-site monitoring service may also be

utilized to communicate any abnormal results to the clinician for adjustments to the plan

of care as needed.

Qualified home infusion therapy suppliers may use all available remote monitoring

methods that are safe and appropriate for their patients and clinicians and as specified in

the plan of care as long as adequate security and privacy protections are utilized.

History

(Rev. 10547, Issued: 12-31-20, Effective: 01-01-21, Implementation: 01-04-21)

Provenance

Source
cms.gov
Retrieved
2026-08-25
Edition
iom-2026-08-25
Content hash
8d704cd8508c190d168d6b53d68b4548bf571d9fd87b72b5a8825893a8752b48
View the official source →

The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.

Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.

Coverage · API docs

Bindinglaw

Point-in-time US law with the receipt attached. Source URL, retrieval time, content hash, and validity dates on every answer.

curl api.binding.law/v1/law/coverage

© 2026 binding.law · a Jubal, Inc. productAttorneys and firms never pay. Ever.